Locations:
Search IconSearch
September 20, 2016/Cancer/News & Insight

ASTRO 2016 – Wednesday, September 28

Please join our staff as we participate or present in the following oral and poster presentations at the 2016 ASTRO Annual Meeting

21016-CCCC-ASCO_650x450

Oral Presentations

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

7:45 a.m.

Co-Authors: Vargo JA, Ward MC, Caudell JJ, Riaz N, Dunlap NE, Isrow D, Zakem SJ, Dault J, Awan MJ, Higgins KA, Beitler JJ, Yao M, Machtay M, Siddiqui F, Trotti AM, Lee NY, Koyfman SA, Heron DE

Optimal Treatment Selection of SBRT and IMRT for Re-Irradiation of Head and Neck Cancer: A Multi-Institution Comparison

160 A/B/C

7:55 a.m.

Presenter: Matthew Ward, MD
Co-Authors: Riaz N, Caudell JJ, Dunlap NE, Isrow D, Zakem SJ, Dault J, Awan MJ, Vargo JA, Heron DE, Higgins KA, Beitler JJ, Yao M, Machtay M, Siddiqui F, Trotti AM, Lee NY, Koyfman SA

Multi-Institution Analysis of IMRT-based Re-Irradiation for Head and Neck Cancer: Prognostic Factors and Recursive Partitioning Analysis for Overall Survival

160 A/B/C

8:05 a.m.

Co-Authors: Caudell JJ, Ward MC, Koyfman S, Riaz N, Dunlap NE, Isrow D, Zakem SJ, Awan MJ, Vargo J, Heron DE, Higgins KA, Beitler JJ, Yao M, Machtay M, Trotti A, Siddiqui F, Lee N

Multi-Institution Analysis of Re-Irradiation for Head and Neck Cancer: Improved Risk-Benefit Profile in the IMRT Era

160 A/B/C

1:40 p.m.

Presenter: Ehsan Balagamwala, MD
Co-Author: Miller JA, Reddy CA, Angelov L, Suh JH, Tariq MB, Yang K, Djemil T, Magnelli A, Mohammadi AM, Soeder S, Chao ST

Recursive partitioning analysis is predictive of overall survival for patients undergoing spine radiosurgery for spine metastasis

206 A/B

2:20 p.m.

Co-Authors: Miller JA, Balagamwala EH, Berriochoa C, Angelov L, Suh JH, Tariq MB, Yang K, Magnelli A, Soeder S, Mohammadi AM, Djemil T, Benzel EC, Chao ST

Advertisement

The Impact of Instrumentation upon Local Control following Spine Stereotactic Radiosurgery

206 A/B

4:05 p.m.

Co-Authors: Miller JA, Kotecha R, Mohammadi AM, Murphy ES, Suh JH, Barnett GH, Vogelbaum MA, Angelov L, Ahluwalia MS, Chao ST

The Economic Implication of Upfront Whole-Brain Radiation Therapy for Patients with Limited Brain Metastasis

206 A/B

4:25 p.m.

Presenter: Bindu Manyam, MD
Co-Authors: Manyam BV, Garsa A, Chin RI, Reddy CA, Gastman B, Vidimos AT, Thorstad W, Yom S, Nussenbaum B, Wang S, Koyfman SA

A Multi-Institutional Comparison of Outcomes of Immunosuppressed and Immunocompetent Patients Treated with Surgery and Radiation Therapy for Cutaneous Squamous Cell Carcinoma of the Head and Neck

104 A/B/C

ePoster

3:15 p.m.

Presenter: Ping Xia, PhD

Authors: Xia P, Yu N, Kolar M, Godley A, Chao S, Tendulkar R, Suh J

Quantitative Measures Improve Safety, Quality, Efficiency in Radiotherapy

Room: 052 A

Advertisement

Related Articles

adverse events from immune checkpoint inhibitors
December 21, 2023/Cancer/News & Insight
Managing Hormone Dysfunction-Related Adverse Events of Immunotherapy for Breast Cancer Treatment

Timing and type of side effects differ greatly from chemotherapy

23-CNR-4274330-CQD-Hero-650×450
October 18, 2023/Cancer/News & Insight
Cleveland Clinic Lerner Research Institute to Host Head & Neck Cancer CME Symposium

Sessions explore treatment advances and multidisciplinary care

23-CNR-4210971-CQD-Hero-650×450 Dr Yu
October 9, 2023/Cancer/News & Insight
Pathway Cross-Talk Suggests New Approach to Glioblastoma Treatment

New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues

23-CNR-4071967-CQD-Hero-650×450 scan for triple-negative breast cancer case study
September 19, 2023/Cancer/News & Insight
Patient With Stage 4 Triple-Negative Breast Cancer in Remission 10 Years After Initial Diagnosis

Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations

23-CNR-4140381-CQD-Hero-650×450 eye toxicities in cancer treatment
September 7, 2023/Cancer/News & Insight
Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood

Early communication between oncologists and ophthalmologist warranted

23-CNR-4185077-CQD-Hero-650×450
August 31, 2023/Cancer/News & Insight
CME Program Takes Multidisciplinary Approach to Colorectal Cancer

Case-based course delves into latest treatment approaches

outreach to underserved communities
June 2, 2023/Cancer/News & Insight
Focus Groups Amplify the Voices of Black Congregants about Disparities in Clinical Trials

Long-term relationship building and engagement key to gaining community trust

Ad